Challenges of Nanotechnology in Cancer Diagnosis and Treatment: A Review of Diagnostic Nanoparticles and Targeted Drug Delivery

Cancer remains one of the deadliest diseases in ۲۰۲۴, with significant challenges in diagnosis and treatment despite medical advancements. Nanotechnology, particularly nanoparticles, offers promising potential due to their small size, large surface area, and ability to target cancer cells precisely. This review examines the role of nanotechnology in advancing cancer diagnostics and treatment, focusing on innovations and challenges in nanoparticle applications. A systematic search of studies from ۲۰۲۰ to ۲۰۲۴ revealed that nanocarriers, with their enhanced drug delivery capabilities and reduced toxicity, show significant promise in improving cancer treatment efficacy. However, obstacles such as tumor complexity, potential toxicity, and the need for improved biocompatibility persist. To fully realize the clinical potential of nanotechnology, further research is needed to refine nanoparticle design, address regulatory challenges, and optimize translation from preclinical models to clinical applications. Despite these challenges, nanotechnology holds substantial potential to improve patient outcomes and quality of life through more targeted, personalized cancer therapies.

کلیدواژه ها:

cancer diagnosis ، cancer treatment ، nanoparticles ، targeted drug delivery ، biocompatibility